Products Venture Capital Website www.healthcap.eu Type of business Private | Number of employees ~25 (2015) Founded 1996 Total assets 1 billion EUR | |
![]() | ||
Industry Private Equity and Venture Capital |
Healthcap mycompany
HealthCap is a specialized provider of venture capital within life sciences. HealthCap invests in innovative companies with focus on therapeutics. HealthCap has invested in over 100 companies since inception and completed initial public offerings of more than 35 companies. HealthCap has offices in Stockholm, Oslo and Lausanne.
Contents
- Healthcap mycompany
- Healthcap risk management and liability insurance
- History
- Assets under management
- Investments
- References
Healthcap risk management and liability insurance
History
The firm was founded in 1996 by Björn Odlander and Peder Fredrikson and the first fund was started the same year. As of 2012, HealthCap has established six funds. The first five funds have financed 91 companies, 35 of the companies were start-ups. The most recent fund, HealthCap VI, was established in the spring of 2011. In 2015, HealthCap had approximately 25 employees out of which eleven are partners. The team combines venture capital investing experience with competencies and work experiences from small as well as large companies across the health care industry, spanning disciplines of scientific research, drug development, clinical practice, investment banking, and industry management.
Assets under management
HealthCap has raised six main funds. HealthCap IV-VI are Delaware Limited Partnerships with a Swiss general partner. Investors in HealthCap funds include, among others, Skandia Life Insurance, the 4th and 6th Swedish National Pension Funds, The Kresge Foundation, Mayo Clinic, Northwestern University, University of Michigan, Vanderbilt University and Washington University. In 2012, HealthCap had committed capital exceeding €900 million.
Investments
HealthCap invests in companies developing disruptive technologies that hold the potential to change clinical practice. Over the years the portfolio companies have developed more than 20 pharmaceutical products and over 40 med-tech products to the market. Many of these products, such as Firazyr®, Xofigo®, Tracleer®, are breakthrough therapies addressing life-threatening diseases. Examples of technologies financed by HealthCap are